PUBLISHER: Grand View Research | PRODUCT CODE: 1363007
PUBLISHER: Grand View Research | PRODUCT CODE: 1363007
The U.S. aromatherapy market size is anticipated to reach USD 1.3 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a 10.0% CAGR from 2023 to 2030. Various therapeutic benefits of essential oils can be attributed to high market growth.
There has been a significant rise in self-medication for pain or common illnesses, especially common cold. Essential oils have the potential to naturally treat these conditions. Numerous adverse effects of pharmaceuticals are encouraging user to switch to natural essential oils. For instance, rosemary oil can alleviate symptoms of both cold & cough and headache when inhaled, or can be topically used in skin & hair care. North American Free Trade Area (NAFTA) accounts for a significant portion of essential oils trading, leveraging the growing awareness about aromatherapy in the U.S. and other developed countries. High purchasing power is also a significant factor driving the market. However, various adverse effects associated with aromatherapy are expected to restrain the market.
Majority of the key companies manufacturing aromatherapy products are located in the U.S. Companies such as doTERRA International; Frontier Natural Products Co-op; and Young Living Essential Oils are all based in the U.S. For instance, Aura Cacia Roman Chamomile Essential Oil, a single essential oil developed by Frontier Natural Products Co-op, helps in pain management and provides relaxation.